UT Austin Enzyme Advances Gene Editing | AcademicJobs
Discover how UT Austin researchers engineered Al3Cas12f, a tiny CRISPR enzyme boosting gene editing efficiency to over 80%, paving the way for transformative therapies at leading US universities.
No reviews yet. Be the first to rate David!
David W. Taylor is an Associate Professor in the Department of Molecular Biosciences at the University of Texas at Austin, where he holds the Marvin L. Hackert Professorship in Structural Biology. He earned a B.S. in Biochemistry summa cum laude from Syracuse University in 2008, a Ph.D. in Molecular Biophysics and Biochemistry with distinction from Yale University in 2013, and completed postdoctoral training as a Damon Runyon Fellow at the University of California, Berkeley in 2014.
Taylor’s research focuses on the structural basis of macromolecular machine assembly and function, with particular emphasis on CRISPR RNA-guided adaptive immunity in prokaryotes and genome maintenance and double-strand DNA break repair in eukaryotes, investigated primarily through cryo-electron microscopy. His contributions have been recognized with awards including the American Cancer Society Research Scholar award, Army Young Investigator award, CPRIT Scholar in Cancer Research, Damon Runyon Fellowship, NSF Predoctoral Fellowship, and Barry M. Goldwater Scholarship.
Discover how UT Austin researchers engineered Al3Cas12f, a tiny CRISPR enzyme boosting gene editing efficiency to over 80%, paving the way for transformative therapies at leading US universities.